- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02032719
Improved Self Management in Uncontrolled Systolic Hypertension
January 9, 2014 updated by: Paul Ritvo, York University
Investigating Improved Self Management in Uncontrolled Systolic Hypertension
Patients who receive smartphone-assisted health coaching will have a significantly lower 24 hour ambulatory blood pressure mean than patients who receive just health coaching
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Primary Outcome Measure: Mean 24 hour ambulatory blood pressure
Secondary Outcome Measures: Profile of Mood States-SF Vigor Scale; Satisfaction with Life Scale; Positive and Negative Affect Schedule; Hospital Anxiety and Depression Scale; SF - 12
Study Type
Interventional
Enrollment (Anticipated)
65
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Meysam Pirboglu, MSc
- Phone Number: 4168325893
- Email: meyir@yorku.ca
Study Locations
-
-
Ontario
-
Newmarket, Ontario, Canada, L3Y 2P9
- Recruiting
- Southlake Regional Health Centre
-
Contact:
- Meysam Pirboglu, MSc
- Phone Number: 4168325893
- Email: meyir@yorku.ca
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years to 70 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- 25 - 70 years old;
- mean daytime systolic BP> 130 mm. Hg.
Exclusion Criteria:
- Severe or end-stage organ disease (liver, kidney, heart, lung) or history of diabetic ketoacidosis, or any other illness with expected survival less than 1 year;
- severe cognitive impairment;
- diagnosed psychiatric illness or disability;
- clinical significant cardiac arrhythmia;
- symptomatic orthostatic hypertension;
- pregnancy;
- not fluent in english.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: smartphone assisted lifestyle coaching
6 months of smartphone assisted lifestyle coaching
|
smartphone with software provides self monitoring of exercise, diet and stress reduction; provision of timely reminders; photo-journaling of meals; secure text messaging
|
ACTIVE_COMPARATOR: Lifestyle health coaching
6 months of lifestyle health coaching
|
Lifestyle counseling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24 hour ambulatory blood pressure mean
Time Frame: 6 months follow up from baseline
|
24 hour ambulatory blood pressure assessed at baseline and 6 months follow up in experimental and control groups
|
6 months follow up from baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life self report measures
Time Frame: Baseline and 6 months followup
|
Profile of Mood States - SF Vigor Scale Satisfaction with Life Scale Positive and Negative Affect Schedule Hospital Anxiety and Depression Scale; SF 12
|
Baseline and 6 months followup
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ANTICIPATED)
June 1, 2014
Study Completion (ANTICIPATED)
June 1, 2014
Study Registration Dates
First Submitted
January 6, 2014
First Submitted That Met QC Criteria
January 9, 2014
First Posted (ESTIMATE)
January 10, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
January 10, 2014
Last Update Submitted That Met QC Criteria
January 9, 2014
Last Verified
January 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2012-259
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systolic Hypertension
-
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyCompletedIsolated Systolic HypertensionGermany
-
VALISH studyJapan Cardiovascular Research FoundationCompletedAged | Systolic HypertensionJapan
-
Novartis PharmaceuticalsCompletedSystolic HypertensionUnited States, Spain, Hungary, Korea, Republic of, Argentina, India, Slovakia, Canada, Romania
-
Shanghai Jiao Tong University School of MedicineRecruitingIsolated Systolic HypertensionChina
-
NovartisCompletedStage 2 Systolic HypertensionUnited States
-
Nina HermansUniversity Hospital, AntwerpRecruiting
-
Johns Hopkins UniversityBioMarin PharmaceuticalTerminatedEndothelial Dysfunction | Isolated Systolic HypertensionUnited States
-
Serodus ASAThe Research Council of Norway; Smerud Medical Research International ASCompletedIsolated Systolic HypertensionUnited Kingdom, Finland, Hungary, Norway
-
University of IowaRecruitingHypertension, Systolic | Stiffness, AorticUnited States
-
Khon Kaen UniversityCompletedSystolic Essential HypertensionThailand
Clinical Trials on smartphone-assisted health coaching
-
Oviva AGBern University of Applied Sciences; Swiss Commission for Technology and Innovation and other collaboratorsCompletedObesity | OverweightSwitzerland
-
Mayo ClinicNational Institute on Aging (NIA)CompletedChronic Obstructive Pulmonary Disease | Physical ActivityUnited States
-
University of OttawaOttawa Hospital Research InstituteWithdrawnSuicide | Intentional Self-HarmCanada
-
Habit DesignUniversity of Washington; TriHealth Inc.Recruiting
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
University of California, San FranciscoKaiser PermanenteCompleted
-
Kansas State UniversityUnknown
-
Pack HealthGlaxoSmithKline; University of WashingtonRecruitingMultiple Myeloma | Relapsed Hematologic MalignancyUnited States
-
Northwestern UniversityCompletedPhysical Activity | Systemic Lupus Erythematosus | SleepUnited States
-
York UniversityTerminated